NCT04703790View on ClinicalTrials.gov

Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods

CompletedOBSERVATIONAL
Enrollment

1,208

Participants

Timeline

Start Date

April 7, 2021

Primary Completion Date

April 22, 2021

Study Completion Date

February 18, 2022

Conditions
Covid19Vaccine Acceptability
Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Columbia University

OTHER

NCT04703790 - Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods | Biotech Hunter | Biotech Hunter